||
UGN-102膀胱灌注液是一种创新的丝裂霉素 https://mp.weixin.qq.com/s/642v6XUpCGC2VzkkOH96Bw
http://www.pubmedplus.cn/P/SearchQuickResult?wd=6031d488-de06-4bea-9cf9-a453152e40cf
https://pubmed.ncbi.nlm.nih.gov/39029806/
Urology
. 2024 Jul 18:S0090-4295(24)00572-7.
doi: 10.1016/j.urology.2024.07.017. Online ahead of print.
Low-grade Urothelial Carcinoma Recurs at a Tempo that Naturally Accelerates Over TimeAffiliations expand
PMID: 39029806
https://pubmed.ncbi.nlm.nih.gov/34433303/
Clinical Trial
J Urol
. 2022 Jan;207(1):61-69.
doi: 10.1097/JU.0000000000002186. Epub 2021 Aug 26.
Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm TrialAffiliations expand
PMID: 34433303
PMCID: PMC8667793
http://www.pubmedplus.cn/P/SearchQuickResult?wd=63095dd6-d3c5-48a9-87a0-c0671c9a9286
01. | Humans | 80 篇 | 79.208% |
02. | Urinary Bladder Neoplasms | 76 篇 | 75.248% |
03. | Neoplasm Recurrence, Local | 60 篇 | 59.406% |
04. | Female | 55 篇 | 54.455% |
05. | Aged | 54 篇 | 53.465% |
06. | Male | 54 篇 | 53.465% |
07. | Middle Aged | 44 篇 | 43.564% |
08. | Retrospective Studies | 39 篇 | 38.614% |
09. | Neoplasm Invasiveness | 37 篇 | 36.634% |
10. | Disease Progression | 29 篇 | 28.713% |
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-11-25 18:00
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社